High bone mass gene of 11q13.3

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Using tissue cell culture to make a protein or polypeptide

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C536S023100

Reexamination Certificate

active

10731739

ABSTRACT:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.

REFERENCES:
patent: 5691153 (1997-11-01), Recker et al.
patent: 6545137 (2003-04-01), Todd et al.
patent: 6555654 (2003-04-01), Todd et al.
patent: 6770461 (2004-08-01), Carulli et al.
patent: 6780609 (2004-08-01), Carulli et al.
patent: 2003/0219793 (2003-11-01), Carulli et al.
patent: 2004/0038860 (2004-02-01), Allen et al.
patent: 2005/0196349 (2005-09-01), Wu et al.
patent: WO 97/12903 (1997-04-01), None
patent: WO 98/46743 (1998-10-01), None
patent: WO 99/09054 (1999-02-01), None
patent: WO 99/47529 (1999-09-01), None
patent: WO 00/58496 (2000-10-01), None
patent: WO 01/92891 (2001-12-01), None
patent: WO 02/092000 (2002-11-01), None
R. Lavasseur et al., “LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders,” Joint Bone Spine 72 (2005) pp. 207-214, Elsevier SAS.
Y. Zhang et al., “The LRP5 High-Bone-Mass G171V Mutation Disrupts LRP5 Interaction with Mesd,” Molecular and Cellular Biology, Jun. 2004, pp. 4677-4684, American Society for Microbiology, Washington, DC.
M. Ai et al., “Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling,” Molecular and Cellular Biology, Jun. 2005, pp. 4946-4955, American Society for Microbiology, Washington, DC.
Annex Form PCT/ISA/206 Communication Relating to the Results of the Partial International Search attached to Invitation to Pay Additional Fees dated May 7, 2001 in PCT/US00/16951 filed on Jun. 21, 2000.
A. Courseaux et al., “Homo Sapiens Chromosome 11 Clone BAC67-M-5 MAP 11q13, *** Sequencing in Progress ***, 3 Ordered Pieces”, Database EM—HTG, E.B.I., Hinxton, U.K., Accession No. ACO24123, Mar. 2, 2000, XP002165276, Abstract.
D.L. Koller et al., “Linkage of a QTL Contributing to Normal Variation in Bone Mineral Density to Chromosome 11q12-13”, J. Bone Miner. Res., vol. 13, No. 12, pp. 1903-1908, Dec. 1998, Blackwell Science, Inc., American Society for Bone and Mineral Research, USA.
Michael P. Whyte, “Searching for Gene Defects that Cause High Bone Mass”, Am. J. Hum. Genet., vol. 60; No. 6, pp. 1309-1311, Jun. 1997, The American Society of Human Genetics, USA.
Marion Trommsdorff et al., “Interaction of Cytosolic Adaptor Proteinswith Neuronal Apolipoprotein E Receptors and the Amyloid Precursor Protein”, J. Biol. Chem., vol. 273, No. 50, pp. 33556-33560, Dec. 1998, The American Society for Biochemistry and Molecular Biology, Inc., USA.
G. Schneider et al., “Formation of Focal Adhesions by Osteoblasts Adhering to Different Substrate”, Experimental Cell Research, vol. 214, No. 1, pp. 264-269, Sep. 1994, Academic Press, Inc., USA.
Frederick M. Pavalko et al., “Fluid Shear-Induced Mechanical Signaling in MC3T3-E1 Osteoblasts Requires Cytoskeleton-Integrin Interactions”, Am. J. Physiol., vol. 275, No. 6 (Pt 1), pp. C1591-1601, Dec. 1998, The American Physiological Society, USA.
Mark L. Johnson et al., “Linkage of a Gene Causing High Bone Mass to Human Chromosome 11(11q12-13)”, Am. J. Hum. Genet., vol. 60, No. 6, pp. 1326-1332, Jun. 1997, The American Society of Human Genetics, USA.
Dong-Ho Kim et al., “A New Low Density Lipoprotein Receptor Related Protein, LRP5, is Expressed in Hepatocytes and Adrenal Cortex, and Recognizes Apolipoprotein E”, J. Biochem., vol. 124, No. 6, pp. 1072-1076, Dec. 1998, The Japanese Biochemical Society, JAPAN.
Johnson et al.,Journal of Bone and Mineral Research, 11 (Supplement 1):S255, abstract S661, Aug. 1996.
Nakagawa et al., “Fine Mapping of the Diabetes-Susceptibility Locus, IDDM4, on Chromosome 11q13”,American Journal of Human Genetics, 63(2): 547-56 (Aug. 1998).
Hey et al., “Cloning of a Novel Member of the Low-Density Lipoprotein Receptor Family,”Gene216: 1:103-111 (1998).
Dong et al., “Molecular Cloning and Characterization of LR, Novel LDL Receptor Family Protein with Mitogenic Activity”,Biochemical and Biophysical Research Communication, 251:(3) 784-90 (Oct. 29, 1998).
Bollag et al., “Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors”,Endocrinology, 141:1228-1235, 2000.
Ziegler et al., “Glucococorticoid-Induced Osteoporosis: Prevention and Treatment”,Steroids, 63:344-348, 1998.
Kundu et al., “Role of Polypeptides in the Treatment and Diagnosis of Osteoporosis”,Peptides, 20:523-537, 1999.
Rodan et al., “Therapeutic Approaches to Bone Diseases”,Science, 289:1508-1514, 2000.
Maurer et al., “Lipid Based Systems for the Intracellular Delivery of Genetic Drugs”,Molecular Membrane Biology, 16:129-140 1999.
Verma et al., “Gene Therapy, Promises, Problems, and Prospects”,Nature, 389:239-242, 1997.
Anderson, “Human Gene Therapy”,Nature, 392:25-30, 1998.
Walther et al., “Viral Vectors for Gene Transfer”,Drugs, 60:249-271, 2000.
Johnson et al., “The Gene for High Bone Mass,” Endocrinologist, vol. 12, No. 5, 2002, pp. 445-453, Lippincott Williams & Wilkins, Philadelphia PA.
Search Report issued in European Patent Application EP 02746370, no date.
European Search Report dated May 4, 2004.
U.S. Appl. No. 09/544,398, filed Apr. 5, 2000, Carulli et al.
U.S. Appl. No. 09/543,771, filed Apr. 5, 2000, Carulli et al.
U.S. Appl. No. 09/578,900, filed May 26, 2000, Carulli et al.
U.S. Appl. No. 10/240,851, filed Oct. 4, 2002, Carulli et al.
U.S. Appl. No. 10/680,287, filed Oct. 8, 2003, Askew et al.
U.S. Appl. No. 10/477,173, filed Nov. 10, 2003, Allen et al.
U.S. Appl. No. 10/477,238, filed Apr. 12, 2004, Babij et al.
U.S. Appl. No. 10/731,739, filed Dec. 10, 2003, Carulli et al.
U.S. Appl. No. 10/834,377, filed Apr. 29, 2004, Carulli et al.
Gong et al., “LDL Receptor-Related Protein 5(LRP5)Affects Bone Accrual and Eye Development,” Cell 107, pp. 513-523, Cell Press, Cambridge, Massachusetts, 2001.
Magoori et al., “Severe Hypercholesterolemia, Impaired Fat Tolerance, and Advanced Atheroscleroisis in Mice Lacking Both Low Density Lipoprotein Receptor-related Protein 5 and Apolipoprotein E*,” The Journal of Biological Chemistry 278(13) pp. 11331-11336, The American Society for Biochemistry and Molecular Biology, Inc., Baltimore, Maryland, 2003.
Boyden et al., “High Bone Density Due to a Mutation In LDL-Receptor-Related Protein 5,” The New England Journal of Medicine 346(20), pp. 1513-1521, Massachusetts Medical, Boston, Massachusetts, 2002.
Van Wesenbeeck et al., “Six Novel Missense Mutations in the LDL Receptor-Related Protein 5(LRP5)Gene in Different Conditions with an Increased Bone Density,” Am. J. Human. Genet., 72, pp. 763-771, The University of Chicago Press, Chicago, Illinois, 2003.
Little et al., “A Mutation in the LDL Receptor-Related Protein 5 Gene Results in the Autosomal Dominant High-Bone-Mass Trait,” Am. J. Hum. Genet., 70, pp. 11-19, The University of Chicago Press, Chicago, Illinois, 2002.
Babij et al., “High Bone Mass in Mice Expressing a Mutant LRP5 Gene,” Journal of Bone and Mineral Res

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

High bone mass gene of 11q13.3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High bone mass gene of 11q13.3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High bone mass gene of 11q13.3 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3903119

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.